BELGRADE, Mont., June 16 /PRNewswire/ -- Bacterin International, Inc., a developer of revolutionary bone graft material, today announced a three-year agreement to provide its biologic line of products, OsteoSponge®, OsteoSelect®, OsteoSponge SC®, OsteoWrap®, BacFast®, and OsteoLock®, to the vast Broadlane® nationwide network of hospitals and medical practices. The group purchasing agreement through which any Broadlane customer may elect to purchase products from Bacterin, either directly or through an authorized distributor, became effective May 1, 2010, and follows several months of rigorous testing by Broadlane and its clients.
Broadlane, founded in 1999, is the largest operator of healthcare supply chains in the US, managing approximately $10 billion in contract volume, with 1,147 Independent Delivery Networks (IDNs) and hospitals, 5,175 ambulatory care and surgery centers and 33,155 physician practices in its network. Broadlane, in its capacity as a Group Purchasing Organization (GPO), proactively engages its clients to determine engagement and contract strategies. Of the $10 billion in spend processed by Broadlane contracts each year, $4 billion is managed directly by its employees on behalf of clients. Broadlane's meticulous testing focuses on value analysis and clinically aligns the contracting process, ensuring that its clients have access to the best-of-breed products to improve patients' quality of care.
"The Broadlane engagement is an important endorsement of Bacterin's products. We recognize Broadlane's strong reputation in delivering streamlined supply chain and strategic sourcing services with particularly high portfolio utilizatio